← SynDRA
PRAMOXINE
SynDRA canonical compound SYN0004505 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | topical anesthetic |
| Indication | corticosteroid-responsive dermatoses |
| Disease area | dermatology |
All known targets
- Pgrmc1
- SCN1A
- SCN2A
- SCN3A
- SIGMAR1
Mechanisms of action (all sources)
Drug classes
- Anesthetics
- Anesthetics, Local
- Central Nervous System Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- D04A · ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
- C05A · AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Cross-references
Synonyms
- pramocaine
- pramocaine hydrochloride
- pramoxine hydrochloride
- pramocain
- pramoxin
- pramoxine HCl
- Pramocaine
- Pramocaina
- Pramoxine hydrochloride
- Pramoxine HCl
- Pramocaine hydrochloride
- Prax Lotion
- Tronolane
- Tronothane hydrochloride
- ProctoFoam-NS
- Pramocaine (hydrochloride)
- UNII-88AYB867L5
- HSDB 7220
- EINECS 211-293-1
- NSC 25573
- Pramoxine hydrochloride [USP]
- MLS000028604
- Morpholine, 4-[3-(4-butoxyphenoxy)propyl]-, hydrochloride
- 88AYB867L5
- 4-(3-(p-Butoxyphenoxy)propyl)morpholine hydrochloride
- p-Butoxyphenyl gamma-morpholinopropyl ether hydrochloride
- gamma-Morpholinopropyl 4-n-butoxyphenyl ether hydrochloride
- SMR000058670
- 4-(3-(p-Butoxyphenoxy)propyl)morpholine
- Proxazocain
- pramocainum
- 4-[3-(4-Butoxyphenoxy)propyl]morpholine
- p-Butoxyphenyl gamma-morpholinopropyl ether
- gamma-Morpholinopropyl 4-n-butoxyphenyl ether
- CHEBI:8357
- 4-(3-(4-butoxyphenoxy)propyl)morpholine
- RefChem:55901
Reported adverse events
- Hypertrichosis
- Perioral dermatitis
- Milia
- Acne
- Folliculitis
- Miliaria
- Skin atrophy
Look up PRAMOXINE in the interactive SynDRA portal →